$748 Million is the total value of Iron Triangle Partners LP's 23 reported holdings in Q2 2023. The portfolio turnover from Q1 2023 to Q2 2023 was 114.3% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| ICLR | Buy | ICON PLC | $87,570,000 | +115.8% | 350,000 | +84.2% | 11.71% | +100.0% |
| UHS | New | UNIVERSAL HLTH SVCS INCcl b | $74,151,900 | – | 470,000 | +100.0% | 9.91% | – |
| ABBV | Buy | ABBVIE INC | $60,628,500 | +18.9% | 450,000 | +40.6% | 8.10% | +10.2% |
| EXAS | New | EXACT SCIENCES CORP | $46,950,000 | – | 500,000 | +100.0% | 6.28% | – |
| BSX | New | BOSTON SCIENTIFIC CORP | $45,976,500 | – | 850,000 | +100.0% | 6.15% | – |
| UTHR | New | UNITED THERAPEUTICS CORP DEL | $44,150,000 | – | 200,000 | +100.0% | 5.90% | – |
| ESTA | Buy | ESTABLISHMENT LABS HLDGS INC | $36,905,731 | +28.2% | 537,906 | +26.6% | 4.93% | +18.8% |
| PACB | Buy | PACIFIC BIOSCIENCES CALIF IN | $31,920,000 | +19.8% | 2,400,000 | +4.3% | 4.27% | +11.1% |
| ALGN | New | ALIGN TECHNOLOGY INC | $22,986,600 | – | 65,000 | +100.0% | 3.07% | – |
| GKOS | New | GLAUKOS CORP | $22,075,100 | – | 310,000 | +100.0% | 2.95% | – |
| TXG | Buy | 10X GENOMICS INC | $21,219,200 | +8.7% | 380,000 | +8.6% | 2.84% | +0.7% |
| NBIX | New | NEUROCRINE BIOSCIENCES INCput | $18,482,800 | – | 196,000 | +100.0% | 2.47% | – |
| BKD | Buy | BROOKDALE SR LIVING INC | $17,653,750 | +121.6% | 4,183,353 | +54.9% | 2.36% | +105.4% |
| TMDX | New | TRANSMEDICS GROUP INC | $15,116,400 | – | 180,000 | +100.0% | 2.02% | – |
| SWTX | Buy | SPRINGWORKS THERAPEUTICS INC | $12,190,596 | +51.5% | 464,935 | +48.7% | 1.63% | +40.4% |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2023-08-14
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| DEXCOM INC | 13 | Q2 2024 | 7.7% |
| ABBVIE INC | 12 | Q2 2024 | 8.1% |
| ICON PLC | 12 | Q1 2024 | 11.7% |
| ACADIA HEALTHCARE COMPANY IN | 12 | Q2 2024 | 8.0% |
| HORIZON THERAPEUTICS PUB LTD | 12 | Q3 2022 | 9.0% |
| GUARDANT HEALTH INC | 12 | Q3 2022 | 6.1% |
| SURGERY PARTNERS INC | 12 | Q4 2023 | 6.4% |
| CHARLES RIV LABS INTL INC | 11 | Q1 2023 | 7.8% |
| INTUITIVE SURGICAL INC | 11 | Q2 2024 | 6.1% |
| BOSTON SCIENTIFIC CORP | 10 | Q3 2023 | 8.9% |
View Iron Triangle Partners LP's complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| N-PX | 2024-08-30 |
| 13F-HR | 2024-08-14 |
| 13F-HR | 2024-05-15 |
| 13F-HR | 2024-02-14 |
| 13F-HR | 2023-11-14 |
| 13F-HR | 2023-08-14 |
| 13F-HR | 2023-05-15 |
| 13F-HR | 2023-02-14 |
| 13F-HR | 2022-11-14 |
| 13F-HR | 2022-08-15 |
View Iron Triangle Partners LP's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.